2018
DOI: 10.1186/s12889-018-5077-6
|View full text |Cite
|
Sign up to set email alerts
|

Low use of artemisinin-based combination therapy for febrile children under five and barriers to correct fever management in Benin: a decade after WHO recommendation

Abstract: BackgroundArtemisinin-based combination therapy (ACT), used to treat uncomplicated malaria cases, is one of the main strategies of malaria control and elimination. One of the main objectives of the Benin National Malaria Control Program’s (NMCP) strategic plan is to ensure that at least 80% of uncomplicated malaria is treated with ACT within 24 h. Therefore, it was of great interest to measure whether the country case management of fever amongst children under five, adhered to the NMCP’s strategic plan and loo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 46 publications
0
4
0
Order By: Relevance
“…Also, in a study in one LGA in Kaduna state (Nigeria) [ 16 ] a lower proportion (45.2%) of the under 5 years old children, who sought care for febrile illness within 48 h, received ACT. In a study in Benin [ 21 ], a much lower proportion took ACT and paracetamol while a much higher proportion took traditional medicine (herbal tea). In another study in Uganda [ 22 ], a lower proportion (26.3%) of those who took an anti-malarial drug took an ACT.…”
Section: Discussionmentioning
confidence: 99%
“…Also, in a study in one LGA in Kaduna state (Nigeria) [ 16 ] a lower proportion (45.2%) of the under 5 years old children, who sought care for febrile illness within 48 h, received ACT. In a study in Benin [ 21 ], a much lower proportion took ACT and paracetamol while a much higher proportion took traditional medicine (herbal tea). In another study in Uganda [ 22 ], a lower proportion (26.3%) of those who took an anti-malarial drug took an ACT.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4] The coordination dilemma has significant implications on the availability of artemisininbased combination therapies (ACTs) that are used to treat malaria in several countries within sub-Saharan Africa. [5][6][7] Presently, malaria ranks as one of the primary factors for disease and death in low-income countries, 8,9 even though there have been several efforts in the recent past that aimed to cut down the growing burden of malaria disease. While several interventions have focused on preventive (such as the provision of treated mosquito nets) and various therapeutic approaches, malaria has remained one of the oldest and deadliest diseases known to humankind.…”
Section: Introductionmentioning
confidence: 99%
“…Presently, malaria ranks as one of the primary factors for disease and death in low-income countries, 8 , 9 even though there have been several efforts in the recent past that aimed to cut down the growing burden of malaria disease. While several interventions have focused on preventive (such as the provision of treated mosquito nets) and various therapeutic approaches, malaria has remained one of the oldest and deadliest diseases known to humankind.…”
Section: Introductionmentioning
confidence: 99%
“…However, achieving quality care presents a significant challenge, especially in low-income countries (Khuluza and Heide, 2017). Malaria has remained one of the oldest and deadliest diseases of humankind (Shretta, et al, 2017), especially among children under five and expectant mothers (Damien, et al, 2018). Currently, international efforts focus on malaria eradication by rolling out new technologies, and through substantial growth in the political and financial commitment by countries, regions, and their global partners by 2050 (Feachem, et al, 2019), especially in Africa (Alonso, 2016).…”
Section: Introductionmentioning
confidence: 99%